Using CTA Measures to Define Cardiac Risk In NFL Alumni
Launched by HEARTFLOW, INC. · Feb 12, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The GAMEFILM Registry is a research study looking at heart health in retired NFL players, specifically focusing on a condition called coronary artery disease (CAD), which affects blood flow to the heart. This study aims to gather important information about heart health in former players to better understand their risk for heart disease. The trial is currently recruiting participants, and any retired NFL player can join, as long as they meet certain criteria related to heart imaging tests.
If you are a retired NFL player, you might be eligible to participate in this study. Participants will undergo specific heart tests to assess their coronary artery condition. Being part of this study can help researchers learn more about heart disease and may lead to improved care for former athletes. It's an opportunity to contribute to important research while also getting valuable information about your heart health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Retired NFL player
- Exclusion Criteria:
- • CCTA not successfully processed for FFRct and AI-Plaque
About Heartflow, Inc.
HeartFlow, Inc. is a pioneering healthcare technology company focused on transforming cardiovascular care through innovative, non-invasive solutions. Utilizing advanced computational fluid dynamics and artificial intelligence, HeartFlow provides critical insights into coronary artery disease, enabling personalized treatment plans and improved patient outcomes. Their flagship product, the HeartFlow Analysis, leverages advanced imaging to create a detailed model of coronary blood flow, assisting healthcare professionals in making informed clinical decisions. Committed to enhancing the quality of care, HeartFlow collaborates with healthcare providers and researchers to advance the understanding and management of heart disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Greenwood Village, Colorado, United States
Patients applied
Trial Officials
Jeffrey Boone
Principal Investigator
Boone Heart Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported